Biotech · Private company
Nerre Therapeutics Ltd.
Track this companyFree. Adds Nerre Therapeutics Ltd. to your Dealase workspace and tells you when its record changes.
Clinical trials40 recruiting or active
Pipeline programs2From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline2
- Orvepitant MaleatePhase 2 · Chronic Refractory CoughClinicalTrials.gov · fetched Nov 12, 2026
- Orvepitant MaleatePhase 2 · CoughClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials4
- Efficacy and Safety Study of Orvepitant for Chronic Cough in Patients With Idiopathic Pulmonary FibrosisPHASE2 · COMPLETED · started Aug 1, 2022ClinicalTrials.gov NCT05185089 · fetched Nov 12, 2026
- A Study of BAY3427080 (NT-814) in the Treatment of Moderate to Severe Post-menopausal Vasomotor SymptomsPHASE2 · COMPLETED · started Nov 20, 2018ClinicalTrials.gov NCT03596762 · fetched Nov 12, 2026
- A Dose-ranging Study of Orvepitant in Patients With Chronic Refractory CoughPHASE2 · COMPLETED · started May 22, 2017ClinicalTrials.gov NCT02993822 · fetched Nov 12, 2026
- Evaluation of the Pharmacokinetics and Safety of BAY3427080 (NT-814) in Post-Menopausal Women With Vasomotor SymptomsPHASE1_PHASE2 · COMPLETED · started Aug 1, 2016ClinicalTrials.gov NCT02865538 · fetched Nov 12, 2026